# Den Europæiske Unions C 204/28.

| | ISSN 1977-0871 |
| --- | --- |
| Den Europæiske Unions
  Tidende | C 204 |
| | |
| Dansk udgave | Meddelelser og oplysninger | 64. årgang28. maj 2021 |

ISSN 1977-0871

Den Europæiske Unions

Tidende

C 204

Dansk udgave

Meddelelser og oplysninger

64. årgang28. maj 2021

---

| Indhold | Side |
| --- | --- |
| | IV   Oplysninger |
| | OPLYSNINGER FRA DEN EUROPÆISKE UNIONS INSTITUTIONER, ORGANER, KONTORER OG AGENTURER |
| | Europa-Kommissionen |
| 2021/C 204/01 | Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. april 2021 til 30. april 2021(Offentliggjort i henhold til artikel 13 eller artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004) | 1 |
| 2021/C 204/02 | Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. april 2021 til 30. april 2021(Afgørelser truffet i henhold til artikel 34 i direktiv 2001/83/EF eller artikel 38 i direktiv 2001/82/EF) | 10 |

Indhold

Side

IV   Oplysninger

OPLYSNINGER FRA DEN EUROPÆISKE UNIONS INSTITUTIONER, ORGANER, KONTORER OG AGENTURER

Europa-Kommissionen

2021/C 204/01

Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. april 2021 til 30. april 2021(Offentliggjort i henhold til artikel 13 eller artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004)

(Offentliggjort i henhold til artikel 13 eller artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004)

1

2021/C 204/02

Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. april 2021 til 30. april 2021(Afgørelser truffet i henhold til artikel 34 i direktiv 2001/83/EF eller artikel 38 i direktiv 2001/82/EF)

(Afgørelser truffet i henhold til artikel 34 i direktiv 2001/83/EF eller artikel 38 i direktiv 2001/82/EF)

10

---

| DA | |
| --- | --- |

DA

---

IV Oplysninger

OPLYSNINGER FRA DEN EUROPÆISKE UNIONS INSTITUTIONER, ORGANER, KONTORER OG AGENTURER

Europa-Kommissionen

| 28.5.2021 | DA | Den Europæiske Unions Tidende | C 204/1 |
| --- | --- | --- | --- |

28.5.2021

DA

Den Europæiske Unions Tidende

C 204/1

---

Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. april 2021 til 30. april 2021

(Offentliggjort i henhold til artikel 13 eller artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004 (1))

(2021/C 204/01)

—   Udstedelse af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

| Dato for afgørelser | Lægemidlets navn | INN-navn (International Non-Proprietary Name) | Indehaver af markedsføringstilladelsen | Nummer i EF-registret | Lægemiddelform | ATC-kode (Anatomical Therapeutic Chemical Code) | Dato for notifikation |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 21.4.2021 | Abevmy | bevacizumab | Mylan IRE Healthcare Limited |
| Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland |

Dato for afgørelser

Lægemidlets navn

INN-navn (International Non-Proprietary Name)

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Lægemiddelform

ATC-kode (Anatomical Therapeutic Chemical Code)

Dato for notifikation

21.4.2021

Abevmy

bevacizumab

Mylan IRE Healthcare Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

EU/1/20/1515

Koncentrat till infusionsvaeske, opløsning

L01XC07

22.4.2021

21.4.2021

JEMPERLI

dostarlimab

| GlaxoSmithKline (Ireland) Limited |
| --- |
| 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland |

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/21/1538

Koncentrat till infusionsvaeske, opløsning

L01XC40

22.4.2021

21.4.2021

Lextemy

bevacizumab

| Mylan IRE Healthcare Limited |
| --- |
| Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland |

Mylan IRE Healthcare Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

EU/1/20/1516

Koncentrat till infusionsvaeske, opløsning

L01XC07

22.4.2021

26.4.2021

Abiraterone Accord

abirateronacetat

| Accord Healthcare S.L.U. |
| --- |
| World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España |

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/20/1512

Filmovertrukket tablet

Tablet

L02BX03

30.4.2021

30.4.2021

Orladeyo

berotralstat

| Biocryst Ireland Limited |
| --- |
| Block 4, Harcourt Centre, Harcourt Road, Dublin 2, D02 HW77, Ireland |

Biocryst Ireland Limited

Block 4, Harcourt Centre, Harcourt Road, Dublin 2, D02 HW77, Ireland

EU/1/21/1544

Kapsler, hårde

B06AC

4.5.2021

30.4.2021

Sibnayal

kaliumcitrat/kaliumhydrogencarbonat

| ADVICENNE |
| --- |
| 22, rue de la Paix, 75002 Paris, France |

ADVICENNE

22, rue de la Paix, 75002 Paris, France

EU/1/20/1517

Depotgranulat

A12BA30

3.5.2021

—   Ændring af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

| Dato for afgørelser | Lægemidlets navn | Indehaver af markedsføringstilladelsen | Nummer i EF-registret | Dato for notifikation |
| --- | --- | --- | --- | --- |
| 7.4.2021 | Effentora | Teva B.V. |
| Swensweg 5, 2031 GA Haarlem, Nederland |

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

7.4.2021

Effentora

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/08/441

8.4.2021

7.4.2021

Instanyl

| Takeda Pharma A/S |
| --- |
| Dybendal Alle 10, 2630 Taastrup, Danmark |

Takeda Pharma A/S

Dybendal Alle 10, 2630 Taastrup, Danmark

EU/1/09/531

8.4.2021

7.4.2021

Trimbow

| Chiesi Farmaceutici S.p.A. |
| --- |
| Via Palermo 26/A, 43122 Parma, Italia |

Chiesi Farmaceutici S.p.A.

Via Palermo 26/A, 43122 Parma, Italia

EU/1/17/1208

8.4.2021

8.4.2021

Vaxzevria

| AstraZeneca AB |
| --- |
| 151 85 Södertälje, Sverige |

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/21/1529

8.4.2021

13.4.2021

Aerinaze

| N.V. Organon |
| --- |
| Kloosterstraat 6, 5349 AB Oss, Nederland |

N.V. Organon

Kloosterstraat 6, 5349 AB Oss, Nederland

EU/1/07/399

16.4.2021

13.4.2021

Deltyba

| Otsuka Novel Products GmbH |
| --- |
| Erika-Mann-Straße 21, 80636 München, Deutschland |

Otsuka Novel Products GmbH

Erika-Mann-Straße 21, 80636 München, Deutschland

EU/1/13/875

14.4.2021

13.4.2021

Neoclarityn

| N.V. Organon |
| --- |
| Kloosterstraat 6, 5349 AB Oss, Nederland |

N.V. Organon

Kloosterstraat 6, 5349 AB Oss, Nederland

EU/1/00/161

22.4.2021

13.4.2021

OPDIVO

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland |

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/15/1014

14.4.2021

13.4.2021

Orgalutran

| N.V. Organon |
| --- |
| Kloosterstraat 6, 5349 AB Oss, Nederland |

N.V. Organon

Kloosterstraat 6, 5349 AB Oss, Nederland

EU/1/00/130

16.4.2021

13.4.2021

Vantavo

| N.V. Organon |
| --- |
| Kloosterstraat 6, 5349 AB Oss, Nederland |

N.V. Organon

Kloosterstraat 6, 5349 AB Oss, Nederland

EU/1/09/572

16.4.2021

14.4.2021

Comirnaty

| BioNTech Manufacturing GmbH |
| --- |
| An der Goldgrube 12, 55131 Mainz, Deutschland |

BioNTech Manufacturing GmbH

An der Goldgrube 12, 55131 Mainz, Deutschland

EU/1/20/1528

14.4.2021

15.4.2021

Natpar

| Shire Pharmaceuticals Ireland Limited |
| --- |
| Blocks 2 & 3 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, Ireland |

Shire Pharmaceuticals Ireland Limited

Blocks 2 & 3 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, Ireland

EU/1/15/1078

16.4.2021

15.4.2021

Sarclisa

| Sanofi-Aventis groupe |
| --- |
| 54 rue La Boétie, 75008 Paris, France |

Sanofi-Aventis groupe

54 rue La Boétie, 75008 Paris, France

EU/1/20/1435

16.4.2021

15.4.2021

Xromi

| Nova Laboratories Ireland Limited |
| --- |
| 3rd Floor, Ulysses House, Foley Street, Dublin 1, D01 W2T2, Ireland |

Nova Laboratories Ireland Limited

3rd Floor, Ulysses House, Foley Street, Dublin 1, D01 W2T2, Ireland

EU/1/19/1366

16.4.2021

16.4.2021

Cholestagel

| CHEPLAPHARM Arzneimittel GmbH |
| --- |
| Ziegelhof 24, 17489 Greifswald, Deutschland |

CHEPLAPHARM Arzneimittel GmbH

Ziegelhof 24, 17489 Greifswald, Deutschland

EU/1/03/268

27.4.2021

16.4.2021

Dynastat

| Pfizer Europe MA EEIG |
| --- |
| Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België |

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/02/209

19.4.2021

16.4.2021

Entecavir Mylan

| Mylan S.A.S. |
| --- |
| 117 allée des Parcs, 69800 Saint Priest, France |

Mylan S.A.S.

117 allée des Parcs, 69800 Saint Priest, France

EU/1/17/1227

26.4.2021

16.4.2021

Epidyolex

| GW Pharma (International) B.V. |
| --- |
| Databankweg 26, 3821AL Amersfoort, Nederland |

GW Pharma (International) B.V.

Databankweg 26, 3821AL Amersfoort, Nederland

EU/1/19/1389

20.4.2021

16.4.2021

EVOTAZ

| Bristol-Myers Squibb/Pfizer EEIG |
| --- |
| Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland |

Bristol-Myers Squibb/Pfizer EEIG

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

EU/1/15/1025

19.4.2021

16.4.2021

Imvanex

| Bavarian Nordic A/S |
| --- |
| Philip Heymans Allé 3, DK-2900 Hellerup, Danmark |

Bavarian Nordic A/S

Philip Heymans Allé 3, DK-2900 Hellerup, Danmark

EU/1/13/855

27.4.2021

16.4.2021

Kyprolis

| Amgen Europe B.V. |
| --- |
| Minervum 7061, 4817 ZK Breda, Nederland |

Amgen Europe B.V.

Minervum 7061, 4817 ZK Breda, Nederland

EU/1/15/1060

20.4.2021

16.4.2021

Macimorelin Consilient Health

| Consilient Health Ltd |
| --- |
| 5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland |

Consilient Health Ltd

5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland

EU/1/18/1337

26.4.2021

16.4.2021

Maviret

| AbbVie Deutschland GmbH & Co. KG |
| --- |
| Knollstrasse, 67061 Ludwigshafen, Deutschland |

AbbVie Deutschland GmbH & Co. KG

Knollstrasse, 67061 Ludwigshafen, Deutschland

EU/1/17/1213

20.4.2021

16.4.2021

Pegasys

| Roche Registration GmbH |
| --- |
| Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland |

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/02/221

26.4.2021

16.4.2021

Pelgraz

| Accord Healthcare S.L.U. |
| --- |
| World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España |

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/18/1313

20.4.2021

16.4.2021

Pemetrexed Lilly

| Eli Lilly Nederland B.V. |
| --- |
| Papendorpseweg 83, 3528 BJ Utrecht, Nederland |

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/15/1034

19.4.2021

16.4.2021

SANCUSO

| Kyowa Kirin Holdings B.V. |
| --- |
| Bloemlaan 2, 2132 NP Hoofddorp, Nederland |

Kyowa Kirin Holdings B.V.

Bloemlaan 2, 2132 NP Hoofddorp, Nederland

EU/1/12/766

26.4.2021

16.4.2021

Taxotere

| Sanofi Mature IP |
| --- |
| 54 rue La Boétie, 75008, Paris, France |

Sanofi Mature IP

54 rue La Boétie, 75008, Paris, France

EU/1/95/002

29.4.2021

16.4.2021

Xaluprine

| Nova Laboratories Ireland Limited |
| --- |
| 3rd Floor, Ulysses House, Foley Street, Dublin 1, Ireland |

Nova Laboratories Ireland Limited

3rd Floor, Ulysses House, Foley Street, Dublin 1, Ireland

EU/1/11/727

19.4.2021

16.4.2021

Xerava

| PAION Deutschland GmbH |
| --- |
| Heussstraße 25, 52078 Aachen, Deutschland |

PAION Deutschland GmbH

Heussstraße 25, 52078 Aachen, Deutschland

EU/1/18/1312

19.4.2021

21.4.2021

Adrovance

| N.V. Organon |
| --- |
| Kloosterstraat 6, 5349 AB Oss, Nederland |

N.V. Organon

Kloosterstraat 6, 5349 AB Oss, Nederland

EU/1/06/364

26.4.2021

21.4.2021

Avamys

| GlaxoSmithKline (Ireland) Limited |
| --- |
| 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland |

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/07/434

28.4.2021

21.4.2021

CABOMETYX

| Ipsen Pharma |
| --- |
| 65 quai Georges Gorse, 92100 Boulogne-Billancourt, France |

Ipsen Pharma

65 quai Georges Gorse, 92100 Boulogne-Billancourt, France

EU/1/16/1136

22.4.2021

21.4.2021

Fosavance

| N.V. Organon |
| --- |
| Kloosterstraat 6, 5349 AB Oss, Nederland |

N.V. Organon

Kloosterstraat 6, 5349 AB Oss, Nederland

EU/1/05/310

26.4.2021

21.4.2021

Fycompa

| Eisai GmbH |
| --- |
| Edmund-Rumpler-Strasse 3, 60549 Frankfurt am Main, Deutschland |

Eisai GmbH

Edmund-Rumpler-Strasse 3, 60549 Frankfurt am Main, Deutschland

EU/1/12/776

22.4.2021

21.4.2021

INCRELEX

| Ipsen Pharma |
| --- |
| 65 quai Georges Gorse, 92100 Boulogne-Billancourt, France |

Ipsen Pharma

65 quai Georges Gorse, 92100 Boulogne-Billancourt, France

EU/1/07/402

22.4.2021

21.4.2021

Insulin aspart Sanofi

| Sanofi-Aventis groupe |
| --- |
| 54 rue La Boétie, 75008 Paris, France |

Sanofi-Aventis groupe

54 rue La Boétie, 75008 Paris, France

EU/1/20/1447

22.4.2021

21.4.2021

Lyumjev

| Eli Lilly Nederland B.V. |
| --- |
| Papendorpseweg 83, 3528 BJ Utrecht, Nederland |

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/20/1422

22.4.2021

21.4.2021

Macimorelin Consilient Health

| Consilient Health Ltd |
| --- |
| 5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland |

Consilient Health Ltd

5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland

EU/1/18/1337

23.4.2021

21.4.2021

Mvasi

| Amgen Technology (Ireland) UC |
| --- |
| Pottery Road, Dun Laoghaire, Co. Dublin, Ireland |

Amgen Technology (Ireland) UC

Pottery Road, Dun Laoghaire, Co. Dublin, Ireland

EU/1/17/1246

26.2.2021

21.4.2021

Mvasi

| Amgen Technology (Ireland) UC |
| --- |
| Pottery Road, Dun Laoghaire, Co. Dublin, Ireland |

Amgen Technology (Ireland) UC

Pottery Road, Dun Laoghaire, Co. Dublin, Ireland

EU/1/17/1246

22.4.2021

21.4.2021

NUBEQA

| Bayer AG |
| --- |
| D-51368 Leverkusen, Deutschland |

Bayer AG

D-51368 Leverkusen, Deutschland

EU/1/20/1432

22.4.2021

21.4.2021

Ontruzant

| Samsung Bioepis NL B.V. |
| --- |
| Olof Palmestraat 10, 2616 LR Delft, Nederland |

Samsung Bioepis NL B.V.

Olof Palmestraat 10, 2616 LR Delft, Nederland

EU/1/17/1241

23.4.2021

21.4.2021

OPDIVO

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland |

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/15/1014

26.4.2021

21.4.2021

Oslif Breezhaler

| Novartis Europharm Limited |
| --- |
| Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland |

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/09/586

22.4.2021

21.4.2021

Pemetrexed Fresenius Kabi

| Fresenius Kabi Deutschland GmbH |
| --- |
| Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe, Deutschland |

Fresenius Kabi Deutschland GmbH

Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe, Deutschland

EU/1/16/1115

23.4.2021

21.4.2021

Qtern

| AstraZeneca AB |
| --- |
| 151 85 Södertälje, Sverige |

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/16/1108

22.4.2021

21.4.2021

Ritonavir Mylan

| Mylan S.A.S. |
| --- |
| 117 allée des Parcs, 69800 Saint Priest, France |

Mylan S.A.S.

117 allée des Parcs, 69800 Saint Priest, France

EU/1/17/1242

23.4.2021

21.4.2021

RoActemra

| Roche Registration GmbH |
| --- |
| Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland |

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/08/492

23.4.2021

21.4.2021

Slenyto

| RAD Neurim Pharmaceuticals EEC SARL |
| --- |
| 4 rue de Marivaux, 75002 Paris, France |

RAD Neurim Pharmaceuticals EEC SARL

4 rue de Marivaux, 75002 Paris, France

EU/1/18/1318

28.4.2021

21.4.2021

Stocrin

| Merck Sharp & Dohme B.V. |
| --- |
| Waarderweg 39, 2031 BN Haarlem, Nederland |

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/99/111

26.4.2021

21.4.2021

Tegsedi

| Akcea Therapeutics Ireland Ltd |
| --- |
| Regus House, Harcourt Centre, Harcourt Road, Dublin 2, Ireland |

Akcea Therapeutics Ireland Ltd

Regus House, Harcourt Centre, Harcourt Road, Dublin 2, Ireland

EU/1/18/1296

22.4.2021

21.4.2021

Trogarzo

| Theratechnologies Europe Limited |
| --- |
| 4th Floor, 2 Hume Street, Dublin 2, D02 DV24, Ireland |

Theratechnologies Europe Limited

4th Floor, 2 Hume Street, Dublin 2, D02 DV24, Ireland

EU/1/19/1359

26.4.2021

21.4.2021

Valdoxan

| Les Laboratoires Servier |
| --- |
| 50 rue Carnot, 92284 Suresnes CEDEX, France |

Les Laboratoires Servier

50 rue Carnot, 92284 Suresnes CEDEX, France

EU/1/08/499

22.4.2021

21.4.2021

Vosevi

| Gilead Sciences Ireland UC |
| --- |
| Carrigtohill, County Cork, T45 DP77, Ireland |

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/17/1223

22.4.2021

22.4.2021

COVID-19 Vaccine Janssen

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg 30, 2340 Beerse, België |

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/20/1525

22.4.2021

26.4.2021

Aerius

| Merck Sharp & Dohme B.V. |
| --- |
| Waarderweg 39, 2031 BN Haarlem, Nederland |

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/00/160

30.4.2021

26.4.2021

Atazanavir Mylan

| Mylan S.A.S. |
| --- |
| 117 allée des Parcs, 69800 Saint Priest, France |

Mylan S.A.S.

117 allée des Parcs, 69800 Saint Priest, France

EU/1/16/1091

27.4.2021

26.4.2021

Kaftrio

| Vertex Pharmaceuticals (Ireland) Limited |
| --- |
| 28-32 Pembroke Street Upper, Dublin 2, D02 EK84, Ireland |

Vertex Pharmaceuticals (Ireland) Limited

28-32 Pembroke Street Upper, Dublin 2, D02 EK84, Ireland

EU/1/20/1468

5.5.2021

26.4.2021

Kalydeco

| Vertex Pharmaceuticals (Ireland) Limited |
| --- |
| 28-32 Pembroke Street Upper, Dublin 2, D02 EK84, Ireland |

Vertex Pharmaceuticals (Ireland) Limited

28-32 Pembroke Street Upper, Dublin 2, D02 EK84, Ireland

EU/1/12/782

5.5.2021

26.4.2021

Levetiracetam Hospira

| Pfizer Europe MA EEIG |
| --- |
| Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België |

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/13/889

28.4.2021

26.4.2021

Saxenda

| Novo Nordisk A/S |
| --- |
| Novo Allé, 2880 Bagsvaerd, Danmark |

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/15/992

5.5.2021

28.4.2021

Bortezomib Hospira

| Pfizer Europe MA EEIG |
| --- |
| Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België |

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/16/1114

29.4.2021

30.4.2021

Benlysta

| GlaxoSmithKline (Ireland) Limited |
| --- |
| 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland |

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/11/700

4.5.2021

30.4.2021

Cervarix

| GlaxoSmithKline Biologicals S.A. |
| --- |
| rue de l'Institut 89, 1330 Rixensart, Belgique |

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/07/419

4.5.2021

30.4.2021

Dasselta

| KRKA d d., Novo mesto |
| --- |
| Šmarješka cesta 6, 8501 Novo mesto, Slovenija |

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/11/739

4.5.2021

30.4.2021

Desloratadine Teva

| Teva B.V. |
| --- |
| Swensweg 5, 2031 GA Haarlem, Nederland |

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/11/732

3.5.2021

30.4.2021

Jardiance

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland |

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/14/930

4.5.2021

30.4.2021

Kigabeq

| ORPHELIA Pharma SAS |
| --- |
| 85 boulevard Saint-Michel, 75005 Paris, France |

ORPHELIA Pharma SAS

85 boulevard Saint-Michel, 75005 Paris, France

EU/1/18/1302

4.5.2021

30.4.2021

Mylotarg

| Pfizer Europe MA EEIG |
| --- |
| Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België |

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/18/1277

4.5.2021

30.4.2021

NULOJIX

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland |

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/11/694

4.5.2021

30.4.2021

Remsima

| Celltrion Healthcare Hungary Kft. |
| --- |
| Váci út 1-3. WestEnd Office Building B torony, 1062 Budapest, Magyarország |

Celltrion Healthcare Hungary Kft.

Váci út 1-3. WestEnd Office Building B torony, 1062 Budapest, Magyarország

EU/1/13/853

3.5.2021

30.4.2021

Sprycel

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland |

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/06/363

4.5.2021

30.4.2021

Strimvelis

| Orchard Therapeutics (Netherlands) B.V. |
| --- |
| Prins Bernhardplein 200, 1097 JB, Noord-Holland, Amsterdam, Nederland |

Orchard Therapeutics (Netherlands) B.V.

Prins Bernhardplein 200, 1097 JB, Noord-Holland, Amsterdam, Nederland

EU/1/16/1097

4.5.2021

30.4.2021

Tecentriq

| Roche Registration GmbH |
| --- |
| Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland |

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/17/1220

3.5.2021

30.4.2021

Xtandi

| Astellas Pharma Europe B.V. |
| --- |
| Sylviusweg 62, 2333 BE Leiden, Nederland |

Astellas Pharma Europe B.V.

Sylviusweg 62, 2333 BE Leiden, Nederland

EU/1/13/846

3.5.2021

—   Tilbagekaldelse af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004)

| Dato for afgørelser | Lægemidlets navn | Indehaver af markedsføringstilladelsen | Nummer i EF-registret | Dato for notifikation |
| --- | --- | --- | --- | --- |
| 21.4.2021 | PegIntron | Merck Sharp & Dohme B.V. |
| Waarderweg 39, 2031 BN Haarlem, Nederland |

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

21.4.2021

PegIntron

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/00/131

26.4.2021

—   Udstedelse af markedsføringstilladelse (artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

| Dato for afgørelser | Lægemidlets navn | INN-navn (International Non-Proprietary Name) | Indehaver af markedsføringstilladelsen | Nummer i EF-registret | Lægemiddelform | ATC-kode (Anatomical Therapeutic Chemical Code) | Dato for notifikation |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 14.4.2021 | Credelio Plus | lotilaner / milbemycinoxim | Elanco GmbH |
| Heinz-Lohmann-Straße 4, 27472 Cuxhaven, Deutschland |

Dato for afgørelser

Lægemidlets navn

INN-navn (International Non-Proprietary Name)

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Lægemiddelform

ATC-kode (Anatomical Therapeutic Chemical Code)

Dato for notifikation

14.4.2021

Credelio Plus

lotilaner / milbemycinoxim

Elanco GmbH

Heinz-Lohmann-Straße 4, 27472 Cuxhaven, Deutschland

EU/2/21/271

Tyggetabletter

QP54AB51

15.4.2021

20.4.2021

Ultifend ND IBD

Vaccine mod Newcaste disease, infektiøs bursal sygdom og Marek’s disease (levende rekombinant)

| Ceva-Phylaxia Co. Ltd. |
| --- |
| Szállás u. 5, 1107 Budapest, Magyarország |

Ceva-Phylaxia Co. Ltd.

Szállás u. 5, 1107 Budapest, Magyarország

EU/2/21/272

Koncentrat og solvens til injektionsvæske, suspension.

Pending

22.4.2021

—   Ændring af markedsføringstilladelse (artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

| Dato for afgørelser | Lægemidlets navn | Indehaver af markedsføringstilladelsen | Nummer i EF-registret | Dato for notifikation |
| --- | --- | --- | --- | --- |
| 14.4.2021 | Suprelorin | VIRBAC S.A. |
| 1ère Avenue — 2065 m — L.I.D., 06516 Carros CEDEX, France |

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

14.4.2021

Suprelorin

VIRBAC S.A.

1ère Avenue — 2065 m — L.I.D., 06516 Carros CEDEX, France

EU/2/07/072

19.4.2021

20.4.2021

Convenia

| Zoetis Belgium S.A. |
| --- |
| rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique |

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/06/059

27.4.2021

20.4.2021

Cortavance

| VIRBAC S.A. |
| --- |
| 1ère Avenue — 2065 m — L.I.D., 06516 Carros CEDEX, France |

VIRBAC S.A.

1ère Avenue — 2065 m — L.I.D., 06516 Carros CEDEX, France

EU/2/06/069

26.4.2021

20.4.2021

Proteq West Nile

| Boehringer Ingelheim Vetmedica GmbH |
| --- |
| 55216 Ingelheim am Rhein, Deutschland |

Boehringer Ingelheim Vetmedica GmbH

55216 Ingelheim am Rhein, Deutschland

EU/2/11/129

4.5.2021

20.4.2021

Sevohale

| Chanelle Pharmaceuticals Manufacturing Limited |
| --- |
| Loughrea, Co. Galway, Ireland |

Chanelle Pharmaceuticals Manufacturing Limited

Loughrea, Co. Galway, Ireland

EU/2/16/196

28.4.2021

20.4.2021

Zactran

| Boehringer Ingelheim Vetmedica GmbH |
| --- |
| D-55216 Ingelheim am Rhein, Deutschland |

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/08/082

22.4.2021

26.4.2021

Coliprotec F4/F18

| Elanco GmbH |
| --- |
| Heinz-Lohmann-Straße 4, 27472 Cuxhaven, Deutschland |

Elanco GmbH

Heinz-Lohmann-Straße 4, 27472 Cuxhaven, Deutschland

EU/2/16/202

30.4.2021

26.4.2021

Credelio

| Elanco GmbH |
| --- |
| Heinz-Lohmann-Straße 4, 27472 Cuxhaven, Deutschland |

Elanco GmbH

Heinz-Lohmann-Straße 4, 27472 Cuxhaven, Deutschland

EU/2/17/206

28.4.2021

26.4.2021

Emdocam

| Emdoka bvba |
| --- |
| J. Lijsenstraat 16, 2321 Hoogstraten, België |

Emdoka bvba

J. Lijsenstraat 16, 2321 Hoogstraten, België

EU/2/11/128

27.4.2021

26.4.2021

Enteroporc Coli

| Ceva Santé Animale |
| --- |
| 10 avenue de La Ballastière, 33500 Libourne, France |

Ceva Santé Animale

10 avenue de La Ballastière, 33500 Libourne, France

EU/2/20/268

28.4.2021

26.4.2021

Neptra

| Bayer Animal Health GmbH |
| --- |
| D-51368 Leverkusen, Deutschland |

Bayer Animal Health GmbH

D-51368 Leverkusen, Deutschland

EU/2/19/246

6.5.2021

26.4.2021

Stelfonta

| QBiotics Netherlands B.V. |
| --- |
| Prinses Margrietplantsoen 33, 2595 AM Den Haag, Nederland |

QBiotics Netherlands B.V.

Prinses Margrietplantsoen 33, 2595 AM Den Haag, Nederland

EU/2/19/248

27.4.2021

26.4.2021

Trocoxil

| Zoetis Belgium S.A. |
| --- |
| rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique |

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/08/084

27.4.2021

Alle interesserede kan ved henvendelse på nedenstående adresse få tilsendt den offentlige evalueringsrapport om de pågældende lægemidler og de afgørelser, der er truffet vedrørende disse:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NEDERLANDENE |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NEDERLANDENE

---

(1)  EUT L 136 af 30.4.2004, s. 1.

---

| 28.5.2021 | DA | Den Europæiske Unions Tidende | C 204/10 |
| --- | --- | --- | --- |

28.5.2021

DA

Den Europæiske Unions Tidende

C 204/10

---

Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. april 2021 til 30. april 2021

(Afgørelser truffet i henhold til artikel 34 i direktiv 2001/83/EF (1) eller artikel 38 i direktiv 2001/82/EF (2))

(2021/C 204/02)

—   Udstedelse, videreførsel eller ændring af en national markedsføringstilladelse

| Dato for afgørelser | Lægemidlets navn/navne | INN-navn (International Non-Proprietary Name) | Indehaver/indehavere af markedsføringstilladelsen | Medlemsstat | Dato for notifikation |
| --- | --- | --- | --- | --- | --- |
| 21.4.2021 | Varilrix and associated names | Live attenuated varicella virus (OKA strain) | Se bilaget | Se bilaget | 22.4.2021 |

Dato for afgørelser

Lægemidlets navn/navne

INN-navn (International Non-Proprietary Name)

Indehaver/indehavere af markedsføringstilladelsen

Medlemsstat

Dato for notifikation

21.4.2021

Varilrix and associated names

Live attenuated varicella virus (OKA strain)

Se bilaget

Se bilaget

22.4.2021

---

(1)  EUT L 311 af 28.11.2001, s. 67.

(2)  EUT L 311 af 28.11.2001, s. 1.

---

BILAG

Fortegnelse over lægemidler og lægemiddelform

| Medlemsstat EU/EAA | Indehaver af markedsføringstilladelse
  (Særnavn) | Navn | Styrke | Lægemiddelform | Administration |
| --- | --- | --- | --- | --- | --- |
| Østrig | GlaxoSmithKline Pharma GmbH |
| Euro Plaza, Gebäude I, 4. Stock Wagenseilgasse 3 |
| 1120 Vienna |
| Austria |

Medlemsstat EU/EAA

Indehaver af markedsføringstilladelse

(Særnavn)

Navn

Styrke

Lægemiddelform

Administration

Østrig

GlaxoSmithKline Pharma GmbH

Euro Plaza, Gebäude I, 4. Stock Wagenseilgasse 3

1120 Vienna

Austria

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Belgien

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Levende attenueret Varicella virus (OKA stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Cypern

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Tjekkiet

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Danmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykaer 68 |
| DK-2605 Broendby |
| Denmark |

GlaxoSmithKline Pharma A/S

Nykaer 68

DK-2605 Broendby

Denmark

VARILRIX

Varicella zoster-virus ≥ 2 000 plaque forming unit(s) per dosis

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Estland

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Finland

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Frankrig

| LABORATOIRE GLAXOSMITHKLINE |
| --- |
| 23, RUE FRANCOIS JACOB |
| 92500 RUEIL MALMAISON |
| France |

LABORATOIRE GLAXOSMITHKLINE

23, RUE FRANCOIS JACOB

92500 RUEIL MALMAISON

France

VARILRIX

Levende attenueret Varicella virus (OKA stamme):

Ikke mindre end 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Tyskland

| GlaxoSmithKline GmbH & Co. KG |
| --- |
| Prinzregentenplatz 9 |
| Bogenhausen |
| Bayern |
| 81675 München |
| Germany |

GlaxoSmithKline GmbH & Co. KG

Prinzregentenplatz 9

Bogenhausen

Bayern

81675 München

Germany

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Intramuskulær anvendelse

Grækenland

| GlaxoSmithKline Single Member A.E.B.E. |
| --- |
| Kifissias avenue 266 |
| 152 32 Halandri, Athens |
| Greece |

GlaxoSmithKline Single Member A.E.B.E.

Kifissias avenue 266

152 32 Halandri, Athens

Greece

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Ungarn

| GlaxoSmithKline Kft. |
| --- |
| 43. Csörsz Street |
| 1124 Budapest |
| Hungary |

GlaxoSmithKline Kft.

43. Csörsz Street

1124 Budapest

Hungary

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Island

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykaer 68 |
| DK-2605 Broendby |
| Denmark |

GlaxoSmithKline Pharma A/S

Nykaer 68

DK-2605 Broendby

Denmark

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Italien

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Varicellavirus (OKA stamme): ikke mindre end 2 000 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Letland

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX pulveris un šķīdinātājs injekciju šķīduma pagatavošanai

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Litauen

| GlaxoSmithKline Lietuva UAB |
| --- |
| Ukmergės st. 120 |
| LT-08105 Vilnius |
| Lithuania |

GlaxoSmithKline Lietuva UAB

Ukmergės st. 120

LT-08105 Vilnius

Lithuania

Varilrix milteliai ir tirpiklis injekciniam tirpalui

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Luxembourg

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Levende attenueret Varicella virus (OKA stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Malta

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Norge

| GlaxoSmithKline AS |
| --- |
| Postboks 180, Vinderen |
| 0319 Oslo |
| Norway |

GlaxoSmithKline AS

Postboks 180, Vinderen

0319 Oslo

Norway

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Poland

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

VARILRIX

Ikke mindre end 2000 plaque forming unit(s) af Varicella zoster virus, OKA stamme/0,5 ml

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Portugal

| Smith Kline & French Portuguesa-Produtos Farmaceuticos LDA |
| --- |
| Rua Dr. António Loureiro Borges, 3 Arquiparque, Miraflores Algés |
| 1495-131 Algés |
| Portugal |

Smith Kline & French Portuguesa-Produtos Farmaceuticos LDA

Rua Dr. António Loureiro Borges, 3 Arquiparque, Miraflores Algés

1495-131 Algés

Portugal

VARILRIX

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Rumænien

| GlaxoSmithKline Biologicals SA |
| --- |
| Rue de l’Institut 89 |
| B-1330 Rixensart |
| Belgium |

GlaxoSmithKline Biologicals SA

Rue de l’Institut 89

B-1330 Rixensart

Belgium

Varilrix vaccin varicelic viu atenuat, pulbere şi solvent pentru soluţie injectabilă

Varicellavirus (OKA stamme):

≥ 103.3 plaque forming unit(s)/0,5 ml

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Spanien

| GlaxoSmithKline S.A. |
| --- |
| Severo Ochoa, 2 Parque Tecnologico de Madrid Tres Cantos |
| 28760 Madrid |
| Spain |

GlaxoSmithKline S.A.

Severo Ochoa, 2 Parque Tecnologico de Madrid Tres Cantos

28760 Madrid

Spain

VARILRIX 103,3 UFP/0,5 ml polvo y disolvente para solución inyectable

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Sverige

| GlaxoSmithKline AB |
| --- |
| P.O. Box 516 |
| 169 29 Solna |
| Sweden |

GlaxoSmithKline AB

P.O. Box 516

169 29 Solna

Sweden

Varilrix

Varicellavirus (OKA-stamme):

≥ 103.3 plaque forming unit(s)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

Storbritanien (Nordirland)

| SmithKline Beecham Ltd trading as GlaxoSmithKline UK |
| --- |
| 980, Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

SmithKline Beecham Ltd trading as GlaxoSmithKline UK

980, Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Varilrix 103.3 PFU/0,5  ml, powder and solvent for solution for injection

En dosis (0,5 ml) indeholder: Levende attenueret varicella-zoster (Oka stamme) virus (*1) 103.3 plaque forming units (PFU)

Pulver og solvens til injektionsvæske, opløsning

Subkutan anvendelse

---

(*1)  formeret I MRC5 human diploid celler

---